Literature DB >> 2591461

Lymphocyte adenylate cyclase activity in immunosuppressed patients.

M C Michel1, O E Brodde.   

Abstract

In order to determine whether alterations of adenylate cyclase are involved in the immunosuppressive effect of glucocorticoid/cyclosporin treatment we measured basal, prostaglandin E1-, and forskolin-stimulated cAMP production in lymphocyte membranes from kidney transplant patients undergoing glucocorticoid and/or cyclosporin A treatment. Healthy volunteers and hemodialysis patients with immunosuppression due to uremia served as controls. Whereas adenylate cyclase activity was similar in healthy and uremic controls, basal and stimulated activity were increased threefold in patients with immunosuppressive medication. We suggest that an activation of adenylate cyclase might be involved in the immunosuppressive effects of glucocorticoids and/or cyclosporin A.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2591461     DOI: 10.1007/bf00609422

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  11 in total

Review 1.  Forskolin: its biological and chemical properties.

Authors:  K B Seamon; J W Daly
Journal:  Adv Cyclic Nucleotide Protein Phosphorylation Res       Date:  1986

2.  Effect of dexamethasone on parathyroid hormone stimulation of cyclic AMP in an opossum kidney cell line.

Authors:  R Rizzoli; J P Bonjour
Journal:  J Cell Physiol       Date:  1987-09       Impact factor: 6.384

Review 3.  Modulation of inflammation and immunity by cyclic AMP.

Authors:  H R Bourne; L M Lichtenstein; K L Melmon; C S Henney; Y Weinstein; G M Shearer
Journal:  Science       Date:  1974-04-05       Impact factor: 47.728

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Effect of cyclosporine on total lymphocyte and T-cell counts in renal-transplant recipients.

Authors:  S Shen; M Weir; F Dagher; F Bentley; D Revie; J Ordonez; P Chretien
Journal:  N Engl J Med       Date:  1986-02-13       Impact factor: 91.245

Review 6.  The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response.

Authors:  G M Kammer
Journal:  Immunol Today       Date:  1988 Jul-Aug

7.  Dexamethasone effects on beta-adrenergic receptors and adenylate cyclase regulatory proteins Gs and Gi in ROS 17/2.8 cells.

Authors:  S B Rodan; G A Rodan
Journal:  Endocrinology       Date:  1986-06       Impact factor: 4.736

8.  Human cardiac beta-adrenoceptors: both beta 1- and beta 2-adrenoceptors are functionally coupled to the adenylate cyclase in right atrium.

Authors:  O E Brodde; N O'Hara; H R Zerkowski; N Rohm
Journal:  J Cardiovasc Pharmacol       Date:  1984 Nov-Dec       Impact factor: 3.105

9.  Prednisone and T-cell subpopulations.

Authors:  M R Schuyler; A Gerblich; G Urda
Journal:  Arch Intern Med       Date:  1984-05

10.  Impaired cellular immune responses in chronic renal failure: evidence for a T cell defect.

Authors:  P Kurz; H Köhler; S Meuer; T Hütteroth; K H Meyer zum Büschenfelde
Journal:  Kidney Int       Date:  1986-06       Impact factor: 10.612

View more
  2 in total

1.  Does treatment with beta-adrenoceptor antagonists in vivo alter human adenylate cyclase responsiveness in vitro?

Authors:  M C Michel; M Klüppel; T Philipp; O E Brodde
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

2.  Sensitization by dexamethasone of lymphocyte cyclic AMP formation: evidence for increased function of the adenylyl cyclase catalyst.

Authors:  M C Michel; J Knapp; H Ratjen
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.